Tyk2-IN-14
4-methyl-5-[3-methyl-7-[(6-morpholin-4-ylpyridazin-3-yl)amino]imidazo[4,5-b]pyridin-5-yl]oxypyridine-2-carbonitrile
Molecular Identity
Tyk2-IN-14
4-methyl-5-[3-methyl-7-[(6-morpholin-4-ylpyridazin-3-yl)amino]imidazo[4,5-b]pyridin-5-yl]oxypyridine-2-carbonitrile
PubChem CID: 138560421
2D Structure
Properties
C22H21N9O2
Molecular Formula
443.50
Molecular Weight
g/mol
443.1818
Exact Mass
Da
1.8
XLogP
Drug-like (Lipinski: < 5)
127
TPSA
Good oral absorption (< 140 A²)
1
H-Bond Donors
10
H-Bond Acceptors
699
Complexity
SMILES
Canonical SMILES
SMILES: CC1=CC(=NC=C1OC2=NC3=C(C(=C2)NC4=NN=C(C=C4)N5CCOCC5)N=CN3C)C#NIsomeric SMILES
SMILES: CC1=CC(=NC=C1OC2=NC3=C(C(=C2)NC4=NN=C(C=C4)N5CCOCC5)N=CN3C)C#NSynonyms(20)
GLPG-3667Cadefrecitinib2308520-97-8Tyk2-IN-14GLPG3667CHEMBL55581964-methyl-5-[3-methyl-7-[(6-morpholin-4-ylpyridazin-3-yl)amino]imidazo[4,5-b]pyridin-5-yl]oxypyridine-2-carbonitrilecadefrecitinib [INN]NKX4HH6CWKorb2565106SCHEMBL20917573SCHEMBL30138317GTPL14047EX-A9185BDBM50636900
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Tyk2-IN-14
Loading drug network...